関連する実験動画
Updated: Sep 10, 2025
07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
538
DMH1によるP-Glycoprotein-Mediated Effluxのアロステリック阻害
Zhijun Wang1, Chen Xie2, Maggie Chou1
1Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA 92697, USA.
Biomedicines
|August 28, 2025
まとめ
DMH1は新しいP-glycoprotein (P-gp) 阻害剤で,細胞内毒性を引き起こすことなく薬剤濃度を増やすことで,化学療法効果を高めます. このアロステリック阻害剤は 多剤耐性を克服する有望な効果を示しています
科学分野:
- 生物化学
- 分子生物学
- 薬理学について
背景:
- P-glycoprotein (P-gp) は薬物を積極的にエクスポートし,多剤耐性を引き起こし,化学療法効果を低下させます.
- 現存するP- gp阻害剤は,毒性,特異性の低下,および有効性の制限により,臨床承認を受けていません.
- この研究では,タイプIのBMP受容体阻害剤であるDMH1を,潜在的なP- gp阻害剤として研究しています.
研究 の 目的:
- 新しいP-glycoprotein (P-gp) 阻害剤としてのDMH1の可能性を調査する.
- P-gp媒介による多剤耐性を克服するDMH1の有効性を評価する.
- DMH1のP-gp抑制のメカニズムを解明する.
主な方法:
- P-gp過剰発現と欠陥細胞系における細胞毒性測定 (MTT)
- P- gp抑制を評価するためのカルセインAM保持とダウノルビシン蓄積測定法.
- 運動分析,ATPase活性測定,および抑制メカニズムを決定する分子ドッキング.
主要な成果:
- DMH1は,テストされた細胞系で細胞毒性を示しませんでした.
- DMH1はカルセインAMとダウノルビシンの細胞内蓄積を有意に増加させた.
- 運動分析では,DMH1による非競争性,アロステリック抑制が示され,Vmaxは低下し,Kmは変化しなかった.
- DMH1は投与量に依存してP- gp ATPaseの活性を抑制し,ドッキングによりアロステル結合が示唆された.
結論:
- DMH1は非競争性のアロステリックP- gp阻害剤として作用する.
- DMH1は,関連する細胞毒性なしに細胞内薬物保持を高めます.
- DMH1は,多剤耐性を克服し,化学療法の結果を改善するための新しい戦略を開発するための有望な鉛化合物です.
関連する概念動画
01:06Carrier-Mediated Transport
541
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
541
01:08Allosteric Regulation
59.0K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
59.0K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:58Cooperative Allosteric Transitions
8.0K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.0K
01:19Allosteric Proteins-ATCase
5.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K
00:46Feedback Inhibition
54.5K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
54.5K